Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer

Qiong Yang,1–4,* Chenxi Yin,1,3,4,* Fangxin Liao,1,3,4 Yuanyuan Huang,1,3,4 Wenzhuo He,1,3,4 Chang Jiang,1,3,4 Guifang Guo,1,3,4 Bei Zhang,1,3,4 Liangping Xia1,3,41VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China; 2Department of O...

Full description

Bibliographic Details
Main Authors: Yang Q, Yin CX, Liao FX, Huang YY, He WZ, Jiang C, Guo GF, Zhang B, Xia LP
Format: Article
Language:English
Published: Dove Medical Press 2015-09-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/bevacizumab-plus-chemotherapy-as-third--or-later-line-therapy-in-patie-peer-reviewed-article-OTT

Internet

http://www.dovepress.com/bevacizumab-plus-chemotherapy-as-third--or-later-line-therapy-in-patie-peer-reviewed-article-OTT

Similar Items